Suchergebnisse - "Badr, Mohamed"

PubPharm (6)

1

Design and biological evaluation of 3-substituted quinazoline-2,4(1H,3H)-dione derivatives as dual c-Met/VEGFR-2-TK inhibitors

enthalten in: Journal of enzyme inhibition and medicinal chemistry | 2023

von Hassan, A. | Mubarak, F. | Shehadi, I. | +4

2

Novel 3-phenylquinazolin-2,4(1H,3H)-diones as dual VEGFR-2/c-Met-TK inhibitors : design, synthesis, and biological evaluation

enthalten in: Scientific reports | 2023

von Hassan, A. | Mosallam, A. | Ibrahim, A. | +2

3

Design, synthesis, cytotoxic activities, and molecular docking of chalcone hybrids bearing 8-hydroxyquinoline moiety with dual tubulin/EGFR kinase inhibition

enthalten in: Bioorganic chemistry | 2023

von Amin, M. | Abuo-Rahma, G. | Shaykoon, M. | +6

4

Design, synthesis, in vitro antiproliferative evaluation and in silico studies of new VEGFR-2 inhibitors based on 4-piperazinylquinolin-2(1H)-one scaffold

enthalten in: Bioorganic chemistry | 2022

von Hassan, A. | Badr, M. | Abdelhamid, D. | +3

5

Novel 4-(piperazin-1-yl)quinolin-2(1H)-one bearing thiazoles with antiproliferative activity through VEGFR-2-TK inhibition

enthalten in: Bioorganic & medicinal chemistry | 2021

von Hassan, A. | Badr, M. | Hassan, H. | +2

6

Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors

enthalten in: European journal of medicinal chemistry | 2021

von Bass, A. | El-Zoghbi, M. | Nageeb, E. | +3

1
[1]